GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety.

Trial Profile

GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Acute coronary syndromes; Coronary arteriosclerosis
  • Focus Registrational; Therapeutic Use
  • Acronyms GRAVITAS
  • Sponsors Accumetrics
  • Most Recent Events

    • 15 Jun 2011 Actual end date changed from Aug 2010 to Oct 2010 as reported by ClinicalTrials..gov. (Parent trial, NCT00645918)
    • 15 Mar 2011 Results will be published in the Journal of the American Medical Association, according to an Accumetrics media release.
    • 13 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top